Bifogade filer
PDF
Kurs & Likviditet
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Large Cap Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
The share-based incentive scheme resolved by the 2019 Annual General Meeting where about 35 members of senior management were offered to acquire up to 215,000 call options on repurchased class B shares has been fully subscribed.
The call options will be transferred at a price of SEK 19.10 per call option, equivalent to the market value according to an external independent valuation, applying the Black-Scholes-model. The redemption price of the call options amounts to SEK 306.20, equivalent to 120 percent of the volume-weighted average of the paid market price for the shares during the period from 10 May 2019 to 23 May 2019, inclusive. Each call option entitles the holder to acquire one repurchased class B share during the period from 20 June 2022 to 28 February 2023, inclusive.
Stockholm, June 4, 2019
AddLife AB (publ)
For more information, contact;
Kristina Willgård, CEO, kristina.willgard@add.life,+46 70 510 12 23
Martin Almgren, CFO, martin.almgren@add.life,+46 70 228 15 45
www.add.life
(http://www.add.life)AddLife is an independent player in the Life Science sector, offering high-quality products, services and advice to the private and public sectors, above all in the Nordic region and rest of Europe. AddLife has about 900 employees in some 40 subsidiaries that operate under their own brands. The Group has annual sales of about SEK 2.7 billion. Addlife shares are listed on Nasdaq Stockholm.
This information is information that AddLife AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 4 June 2019 at 11.00 a.m. (CET).